Lv0
0 积分 2024-03-01 加入
Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial
12天前
已完结
Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study
12天前
已完结
Rifasutenizol-based triple therapy for Helicobacter pylori infection
12天前
已完结
Managing dangerous liaisons: lessons from Helicobacter pylori for understanding bacterial carcinogenesis
12天前
已关闭
Evaluation of the VITEK 2 Advanced Expert System performance for predicting resistance mechanisms in Enterobacterales acquired from a hospital-based screening program
12天前
已完结
PCR evaluation of false-positive signals from two automated blood-culture systems
1个月前
已完结
皖公网安备34019202002308
